These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35451243)

  • 1. The understanding of Parkinson's disease through genetics and new therapies.
    Uwishema O; Onyeaka H; Badri R; Yücel AN; Korkusuz AK; Ajagbe AO; Abuleil A; Chaaya C; Alhendawi BHM; Chalhoub E
    Brain Behav; 2022 May; 12(5):e2577. PubMed ID: 35451243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease.
    Béné R; Antić S; Budisić M; Lisak M; Trkanjec Z; Demarin V; Podobnik-Sarkanji S
    Acta Clin Croat; 2009 Sep; 48(3):377-80. PubMed ID: 20055267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
    Siddiqui T; Bhatt LK
    Neurochem Res; 2023 Oct; 48(10):2925-2935. PubMed ID: 37259012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
    Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A
    Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapies for Parkinson's Disease: Progression of Clinical Development.
    Teng JS; Ooi YY; Chye SM; Ling APK; Koh RY
    CNS Neurol Disord Drug Targets; 2021; 20(9):802-813. PubMed ID: 34042040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease.
    Giri B; Seamon M; Banerjee A; Chauhan S; Purohit S; Morgan J; Baban B; Wakade C
    Metab Brain Dis; 2022 Aug; 37(6):1687-1696. PubMed ID: 33881722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein.
    Elgueta D; Chovar O; Ugalde V; Sánchez-Guajardo V; Catenaccio A; Court F; Pacheco R
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease is an autoimmune disease: A reappraisal.
    Bonam SR; Muller S
    Autoimmun Rev; 2020 Dec; 19(12):102684. PubMed ID: 33131704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein: a therapeutic target for Parkinson's disease?
    Maguire-Zeiss KA
    Pharmacol Res; 2008; 58(5-6):271-80. PubMed ID: 18840530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.
    Paccosi E; Proietti-De-Santis L
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.